GB1300128A - Derivatives of cephalosporin - Google Patents
Derivatives of cephalosporinInfo
- Publication number
- GB1300128A GB1300128A GB49516/70A GB4951670A GB1300128A GB 1300128 A GB1300128 A GB 1300128A GB 49516/70 A GB49516/70 A GB 49516/70A GB 4951670 A GB4951670 A GB 4951670A GB 1300128 A GB1300128 A GB 1300128A
- Authority
- GB
- United Kingdom
- Prior art keywords
- acid
- aminomethyl
- cephalosporin
- acylating
- lactams
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
- C07D501/38—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
- C07D501/46—Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
Abstract
1300128 Cephalosporin-γ-lactams ROUSSELUCLAF 19 Oct 1970 [17 Oct 1969] 49516/70 Addition to 1155493 Heading C2A Novel 7 - acylamino - 3 - aminomethyl - cephalosporanic acid-γ-lactams having the Formula I<SP>1</SP> and salts thereof, wherein X is -NO 2 or -NH 2 and may be at position 4, 5, 6 or 7 of the indole nucleus, are prepared by acylating the 7-amino group of 7 - amino - 3 - aminomethyl - cephalosporanic acid-γ-lactam with a (nitro-indol-3<SP>1</SP>-yl)- acetic acid or an N-acylating derivative thereof and optionally subjecting the product to catalytic hydrogenation to convert the -NO 2 group to -NH 2 . The preferred acylating agent is the acid anhydride formed in situ from the acid and a condensing agent (e.g. dicyclohexyl carbodiimide). The hydrogenation is performed in the presence of palladinized charcoal. In an alternative process, the compounds (I<SP>1</SP>) may be prepared by lactamization of an appropriate 7 - acylamino - 3 - aminomethyl cephalosporanic acid or its ester. Pharmaceutical compositions having antibiotic activity against gram-positive and -negative bacteria, comprise a cephalosporin-γ- lactam of Formula I<SP>1</SP> above, or a therapeutically acceptable salt thereof together with a pharmaceutical carrier. The compositions may be in the form of tablets, capsules, pills, powders, oral or injectable liquid forms, topically applicable forms or suppositories.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR696935596A FR2068408B1 (en) | 1969-10-17 | 1969-10-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1300128A true GB1300128A (en) | 1972-12-20 |
Family
ID=9041670
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB49516/70A Expired GB1300128A (en) | 1969-10-17 | 1970-10-19 | Derivatives of cephalosporin |
Country Status (8)
Country | Link |
---|---|
JP (1) | JPS4925951B1 (en) |
BE (1) | BE757639A (en) |
CH (1) | CH531002A (en) |
DE (1) | DE2050966A1 (en) |
FR (1) | FR2068408B1 (en) |
GB (1) | GB1300128A (en) |
IL (1) | IL35312A (en) |
NL (1) | NL7015171A (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20100074949A1 (en) | 2008-08-13 | 2010-03-25 | William Rowe | Pharmaceutical composition and administration thereof |
US8354427B2 (en) | 2004-06-24 | 2013-01-15 | Vertex Pharmaceutical Incorporated | Modulators of ATP-binding cassette transporters |
CN107501099B (en) | 2004-06-24 | 2021-03-19 | 沃泰克斯药物股份有限公司 | Modulators of ATP-binding cassette transporters |
PL1993360T3 (en) | 2005-12-28 | 2017-08-31 | Vertex Pharmaceuticals Incorporated | Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide |
KR101955863B1 (en) | 2009-03-20 | 2019-03-07 | 버텍스 파마슈티칼스 인코포레이티드 | Process for making modulators of cystic fibrosis transmembrane conductance regulator |
US8802700B2 (en) | 2010-12-10 | 2014-08-12 | Vertex Pharmaceuticals Incorporated | Modulators of ATP-Binding Cassette transporters |
IL265430B2 (en) | 2012-02-27 | 2024-08-01 | Vertex Pharma | Pharmaceutical compositions containing a solid dispersion of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamode and uses thereof |
AU2015330923B2 (en) | 2014-10-07 | 2020-03-12 | Vertex Pharmaceuticals Incorporated | Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1584713A (en) * | 1967-01-18 | 1970-01-02 |
-
0
- BE BE757639D patent/BE757639A/en unknown
-
1969
- 1969-10-17 FR FR696935596A patent/FR2068408B1/fr not_active Expired
-
1970
- 1970-09-17 IL IL35312A patent/IL35312A/en unknown
- 1970-09-29 JP JP45084711A patent/JPS4925951B1/ja active Pending
- 1970-10-15 NL NL7015171A patent/NL7015171A/xx unknown
- 1970-10-15 CH CH1526870A patent/CH531002A/en not_active IP Right Cessation
- 1970-10-16 DE DE19702050966 patent/DE2050966A1/en active Pending
- 1970-10-19 GB GB49516/70A patent/GB1300128A/en not_active Expired
Also Published As
Publication number | Publication date |
---|---|
BE757639A (en) | 1971-04-16 |
CH531002A (en) | 1972-11-30 |
IL35312A0 (en) | 1970-11-30 |
IL35312A (en) | 1974-01-14 |
JPS4925951B1 (en) | 1974-07-04 |
NL7015171A (en) | 1971-04-20 |
FR2068408A1 (en) | 1971-08-27 |
FR2068408B1 (en) | 1973-01-12 |
DE2050966A1 (en) | 1971-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB1221855A (en) | Penicillin and cephalosporin derivatives | |
GB1300128A (en) | Derivatives of cephalosporin | |
US3668202A (en) | Process for preparing cepham compounds | |
ES427863A1 (en) | 3-Methylenecephalosporins and process for production thereof | |
GB1413068A (en) | Bromoergolines | |
IL33846A (en) | Derivatives of 1-thiachromone and 4-thionchromone,their preparation and pharmaceutical compositions containing them | |
GB1287786A (en) | O-desacetyl-7-n-acylamino-cephalosporanic acids and process for their manufacture | |
US3297692A (en) | 7-alkylmercaptoacetamidocephalosporanic acid | |
GB1493676A (en) | Antibiotic method and pharmaceutical compositions | |
GB1155493A (en) | Derivatives of Cephalosporin | |
GB1229453A (en) | ||
GB1356437A (en) | Process for the manufacture of cephalosporanic acid derivatives and the derivatives thus obtainable | |
GB1429539A (en) | Derivatives of penam-3-carboxylic acid and cephem-4-carboxylic acid and processes for their manufacture | |
GB1325889A (en) | Derivatives of 7-aminocephalosporanic acid and process for their manufacture | |
US3131184A (en) | Derivatives of 7-aminocephalosporanic acid | |
US3867538A (en) | Enzyme-resistant compositions containing penicillin in combination with 6-apa | |
US3459749A (en) | Orally effective cephalosporin antibiotic | |
GB1299232A (en) | Derivatives of cephalosporin | |
GB1014883A (en) | Therapeutically active derivatives of 7-amino-cephalosporanic acid and process for the manufacture of 7-amino-cephalosporanic acid | |
US3886140A (en) | Penicillin derivatives | |
ES396278A1 (en) | PROCESS FOR THE DECOLORIZATION OF 7-[ alpha -(4-PYRIDYLTHIO)ACETAMIDO]CEPHALOSPORANIC ACID | |
US3905955A (en) | Substituted amino acetamido penicillins | |
GB976225A (en) | Carbocycloxyalkyl cephalosporins | |
US3891634A (en) | P-Hydroxymethylphenylacetamidocephalosporins | |
US3725390A (en) | 6-aminopenicillanic acid derivatives and process for the preparation thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
PCNP | Patent ceased through non-payment of renewal fee |